Clinical-Stage-Biopharmaceutical Biopharma (1,910 companies)
234 Companies
Access all companiesSpotfolio tracks over one million companies in technology industries.
There are 234 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Biopharmaceutical, Clinical-Stage, Biopharmaceutical-Company, Stage-Biopharmaceutical, Clinical, Therapeutics, Stage-Biopharmaceutical-Company, Clinical-Stage-Biopharmaceutical .
Start-ups (29)
Early-stage companies (63)
Established companies (132)
The majority of these companies is located in the following countries.
United States (155)
China (12)
France (9)
United Kingdom (9)
Example Companies
Find companies in your areaAscentage Pharma Ascentage Pharma Group International

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
2018Qinyi Chen SAN DIEGO, CA–December 3, 2018–Ascentage Pharma, a clinical-stage biopharmaceutical company dedicated to the development of novel therapies for ...
ROCKVILLE, Md., Nov. 21, 2018 /PRNewswire/ — Ascentage Pharma, a clinical-stage biopharmaceutical company dedicated to the development of small molecule therapies ...
HONG KONG, CHINA /PRNewswire/ – Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies ...
HONG KONG, CHINA /PRNewswire/ – Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies ...
and HONG KONG, CHINA /PRNewswire – Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies ...
ROCKVILLE, MD and HONG KONG, CHINA | Ascentage Pharma, a global clinical stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies
CHINA— March 26th, 2019—Ascentage Pharma, globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers ...
KONG, March 18, 2019 /PRNewswire/— Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies ...
and Hong Kong—February 14, 2019— Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies ...
Maryland and Hong Kong—January 8, 2019—Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies ...
SUZHOU, China, — December 19, 2018 — Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies
AliveGen USA AliveGen USA, Inc.

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Aadi Bioscience Aadi Bioscience, Inc.

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
Inc. (Aadi), Aadi Bioscience, Inc (Aadi), a privately held clinical stage biopharmaceutical company, today released preliminary data on the ongoing nab-sirolimus ...
January 3, 2019 January, 3 2019, Aadi Bioscience, Inc. (Aadi), a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation ...
Series A Funding 7 May 8, 2017 Aadi Bioscience, Inc. (Aadi), a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation ...
PALISADES, Calif. (Nov 2, 2015) -- AADi Bioscience, LLC, a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation ...
Cancer PACIFIC PALISADES, Calif. (May 20, 2014) -- AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology
Inc. (Aadi), Aadi Bioscience, Inc (Aadi), a privately held clinical stage biopharmaceutical company, today released preliminary data on the ongoing nab-sirolimus ...
January 3, 2019 January, 3 2019, Aadi Bioscience, Inc. (Aadi), a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation ...
Funding 7 by admin / May 8, 2017 Aadi Bioscience, Inc. (Aadi), a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation ...
PALISADES, Calif. (Nov 2, 2015) -- AADi Bioscience, LLC, a clinical stage biopharmaceutical company focused on treating diseases driven by mTOR activation ...
Cancer PACIFIC PALISADES, Calif. (May 20, 2014) -- AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology
Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
InterveXion Therapeutics

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
October 5, 2020 /EINPresswire.com/ -- InterveXion Therapeutics, a clinical-stage biopharmaceutical company, today announced... read more InterveXion Therapeutics ...
Rock, AR (01 May 2020) – InterveXion Therapeutics, a private clinical-stage biopharmaceutical... read more Part 2: Immunotherapies—A New Tool To Treat ...
Release People from Addiction InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment ...
October 5, 2020 /EINPresswire.com/ -- InterveXion Therapeutics, a clinical-stage biopharmaceutical company, today announced... read more InterveXion Therapeutics ...
Rock, AR (01 May 2020) – InterveXion Therapeutics, a private clinical-stage biopharmaceutical... read more Part 2: Immunotherapies—A New Tool To Treat ...
Therapeutics for Addiction InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment
Rock, AR (20 May 2019) – InterveXion Therapeutics, a private clinical-stage biopharmaceutical company focused on developing immunotherapies for substance ...
Rock, AR (13 May 2019) – InterveXion Therapeutics, a private clinical-stage biopharmaceutical company focused on developing immunotherapies for substance
Topics
Search by any topicOnly spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.
Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.
- 1B-Clinical
- 1B-Trial
- 2A-Clinical
- 2A-Clinical-Trial
- 2B-Clinical-Trial
- Clinical-Trial-Evaluating
- Deducting-Underwriting
- Deducting-Underwriting-Discounts
- Patient-Dosed
- Phase-2A-Study
- Phase-2B-Study
- Prospectus-Relating
- Registrational
- Rule-13D
- TEAE
- Therapeutic-Candidate
- Treatment-Emergent
- Upcoming-Investor-Conferences
The following topics addressed by the majority of companies help you discover major players in the field.
- 2A-Study
- 2B-Clinical
- Advanced-Solid
- Advanced-Solid-Tumors
- Biopharmaceutical-Company-Focused
- Biotech
- Book-Running
- Clinical-Pipeline
- Cumulative-Factor
- Dose-Escalation
- Fast-Track-Designation
- Global-Healthcare-Conference
- HTML-Pagination
- Indirect-Beneficial
- LINKBASE
- LifeSci
- Non-Derivative
- Offering-Expenses
- Ongoing-Phase
- Phase-2A
- Phase-2B
- Phase-2B-Clinical
- Product-Candidates
- Secondary-Endpoints
- Securities-Acquired
- Track-Designation
- Underwriting-Discounts
All companies in this field address the following more general topics.
- Biopharmaceutical
- Biopharmaceutical-Company
- Biotechnology
- Board
- Chief
- Clinical
- Clinical-Development
- Clinical-Stage
- Clinical-Stage-Biopharmaceutical
- Clinical-Trials
- Company
- Development
- Director
- Diseases
- Dose
- Dr
- Drug
- Efficacy
- FDA
- Medical
- Medicine
- Novel
- Officer
- Oncology
- Patients
- Ph
- Pharmaceutical
- Phase
- Pipeline
- Preclinical
- Regulatory
- Research
- Scientific
- Stage-Biopharmaceutical
- Stage-Biopharmaceutical-Company
- Study
- Therapeutics
- Therapies
- Treatment
- Trial
- University
Use Cases
Register nowTechnology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.
Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.